Other
Intermittent caloric restriction
Intermittent caloric restriction is an intervention with 3 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
2(67%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_2
1
33%
Ph not_applicable
2
67%
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
3
all time
Status Distribution
Active(2)
Completed(1)
Detailed Status
Active, not recruiting1
Completed1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
2
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 21 (33.3%)
N/A2 (66.7%)
Trials by Status
active_not_recruiting133%
completed133%
recruiting133%
Recent Activity
2 active trials
Showing 3 of 3
active_not_recruitingphase_2
Low Dose TamOxifen and LifestylE Changes for bReast cANcer prevenTion
NCT06033092
recruitingnot_applicable
Intermittent Caloric Restriction in Patients With Mild to Moderate Crohn's Disease
NCT05683730
completednot_applicable
Effects of Intermittent Caloric Restriction in Youth With Cardiometabolic Risk
NCT04011995
Clinical Trials (3)
Showing 3 of 3 trials
NCT06033092Phase 2
Low Dose TamOxifen and LifestylE Changes for bReast cANcer prevenTion
NCT05683730Not Applicable
Intermittent Caloric Restriction in Patients With Mild to Moderate Crohn's Disease
NCT04011995Not Applicable
Effects of Intermittent Caloric Restriction in Youth With Cardiometabolic Risk
All 3 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 3